Publication | Closed Access

Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease1Preliminary parts of this study have been presented in abstract form at the 6th International Conference on Alzheimer's Disease and Related Disorders, July 18–23, 1998, Amsterdam, The Netherlands and at the 28th Annual Meeting of the Society for Neuroscience, November 7–12, 1998, Los Angeles, CA, USA.1

ImmunologyNeurochemical BiomarkersSocial SciencesGeriatric NeurologyNeuroinflammationAlzheimer's DiseaseNeurobiology Of DiseaseNeurologyBrain PathologyNeuroimmunologyInternational ConferenceLos AngelesMolecular NeuroscienceDiscriminant PowerNeurodegenerationProtective MechanismsClinical DisordersNeurodegenerative DiseasesBiomarkersNeuroscienceMedicine